Association between P1NP value and increases in bone mineral density in patients with postmenopausal osteoporosis treated with romosozumab.
Kyosuke HattoriYasuhide KanayamaPublished in: Modern rheumatology (2024)
A high P1NP value at month 3 predicted large increases in both L-BMD and TH-BMD at month 12 in PMO patients treated with romosozumab.